EP3768711

ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    15.3.2019
  • EP published:
    3.5.2023
  • EP application number:
    19714024.7
  • Max expiry date:
    14.3.2039
  • Title in English:
    ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES
  • Language of the patent:
    English

Timeline

Today
15.3.2019EP application
3.5.2023EP Publication

Owner

  • Name:
    Eli Lilly and Company
  • Address:
    Lilly Corporate Center, Indianapolis, IN 46285, US

Inventor

  • Name:
    CARPENITO, Carmine
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    LI, Yiwen
  • Address:
    Indianapolis, Indiana 46206-6288, US

Priority

  • Number:
    201862647016 P
  • Date:
    23.3.2018
  • Country:
    US

Classification

  • Categories:
    C07K 16/28, A61P 35/00

Upload documents